Close

Eli Lilly & Co. (LLY), University of Surrey Enter Partnership for Type 2 Diabetes Treatment

December 22, 2014 10:08 AM EST Send to a Friend
Eli Lilly & Co. (NYSE: LLY) announced a five-year research partnership with the University of Surrey to study health outcomes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login